Vyripharm Enterprises, Inc. and Colorado State University Pueblo Announce Sponsored Research and Facilities Agreement
HOUSTON and PUEBLO, Colo. — Vyripharm Enterprises, Inc. and CSU Pueblo announced today a partnership to support the creation of a comprehensive testing and certification laboratory that will provide the first consistent scientific analysis within cannabinoid research. Vyripharm Enterprises, Inc. (VEI), a Texas biopharmaceutical/biotechnology company based in the Texas Medical Center (TMC), and CSU Pueblo, the host site for the Institute of Cannabis Research (ICR), signed a Sponsored Research and Facilities Agreement (SRA) to support the creation of the new lab. Research within the lab will be carried out through the ICR, the nation’s first multi-disciplinary cannabis research center at a regional, comprehensive institution. Under the terms of the agreement, VEI will provide intellectual property, equipment, and associated funds. A goal of this collaboration is to support a regulatory framework and standardization process in the state of Colorado, under the guidance of public health ...